11th May 2005 07:00
Allergy Therapeutics PLC11 May 2005 Schedule 10 NOTIFICATION OF MAJOR INTERSTS IN SHARES 1. Name of Company Allergy Therapeutics plc 2. Name of shareholder having a major interest Fidelity International Limited 3. Please state whether notification indicates that it is inrespect of holding of the shareholder names in 2 above or in respect of anon-beneficial interest or in the case of children under the age of 18 Non-beneficial interest 4. Name of the registered holder(s) and, if more than oneholder, the number of share held by each of them Nominee/registered name Share held Management CompanyJP Morgan, Bournemouth 1,572,100 Fidelity Inv Services LtdBank of New York, Brussels 359,662 Fidelity Pension Mgmnt(FPM)Bankers Trust London 135,700 FPMCITIBANK London 128,400 FPMClydesdale Bank plc 71,900 FPMJP Morgan, Bournemouth 288,500 FPMMellon Bank 325,400 FPMMidland Securities Services 74,300 FPMNorthern Trust London 618,500 FPMState STR BK and TR Co London 227,084 FPMBrown Bros Harrimn Ltd LUX 650,000 FPMBank of New York, Brussels 81,900 FIL 5. Number of shares/amount of stock acquired 650,000 6. Percentage of issued class 1.03% 7. Number of shares/amount of stock disposed - 8. Percentage of issued class - 9. Class of security Ordinary shares 10. Date of transaction Not notified 11. Date company informed 10th May 2005 12. Total holding following this notification 4,533,446 13. Total percentage holding of issued class following thisnotification 7.20% 14. Any additional items Notifiable interest also comprises of Mr.Edward C. Johnson 3d A principalShareholder of Fidelity International Limited 15. Name of contact and telephone number for queries Ian Postlethwaite - 01903 844721 16. Name and signature of authorised company official responsiblefor make this notification Ian Postlethwaite Date of notification 10th May 2005 The FSA does not give any express or implied warranty as to the accuracy of thisdocument or material and does not accept liability for error or omission. TheFSA is not liable for any damages (including, without limitation, damages forloss of business or loss of profits) arising in contract, tort or otherwise fromthe use of or inability to use this document, or any material contained in it,or from any action or decision taken as a result of using this document or anysuch material. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Allergy Thera.